EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY 4.0

Roux-en-Y Gastric Bypass Improves Adiponectin to Leptin Ratio and Inflammatory Profile in Severely Obese Women with and without Metabolic Syndrome: A Randomized Controlled Trial

Sandra M B P Moreira, André L L Bachi iD, Elias I Jirjos, Carlos A Malheiros iD, Sergio Vencio, Vera L S Alves, Alan R T Sousa, Lucenda A Felipe, Eduardo A Perez, Maria E M Lino, Shayra K A Souza, Juliana M B Santos iD und 7 weitere

Nutrients · 2023

DOI: 10.3390/nu15153312 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Nutrients, 2023. Verfasst von Sandra M B P Moreira und 18 weiteren Autor:innen. Beteiligte Einrichtung: Post Graduation Program in Health Sciences, Santa Casa of São Paulo Medical School, São Paulo 01224-001, SP, Brazil. Hauptthemen laut MEDLINE: Metabolic Syndrome, Gastric Bypass, Obesity, Morbid, Diabetes Mellitus, Type 2. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Council for Scientific and Technological Development, Coordenação de Aperfeicoamento de Pessoal de Nível Superior, Fundação de Apoio a Pesquisa do Estado de Goiás.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Obesity is a troubling public health problem as it increases risks of sleep disorders, respiratory complications, systemic arterial hypertension, cardiovascular diseases, type 2 diabetes mellitus, and metabolic syndrome (MetS). As a measure to counteract comorbidities associated with severe obesity, bariatric surgery stands out. This study aimed to investigate the adiponectin/leptin ratio in women with severe obesity with and without MetS who had undergone Roux-en-Y gastric bypass (RYGB) and to characterize the biochemical, glucose, and inflammatory parameters of blood in women with severe obesity before and after RYGB. Were enrolled females with severe obesity undergoing RYGP with MetS (n = 11) and without (n = 39). Anthropometric data and circulating levels of glucose, total cholesterol, high-density lipoprotein (HDL), non-HDL total cholesterol, low-density lipoprotein (LDL), adiponectin, and leptin were assessed before and 6 months after RYGB. Significant reductions in weight, body mass index, and glucose, total cholesterol, LDL, and leptin were observed after surgery, with higher levels of HDL, adiponectin, and adiponectin/leptin ratio being observed after surgery compared to the preoperative values of those. This study demonstrated that weight loss induced by RYGB in patients with severe obesity with or without MetS improved biochemical and systemic inflammatory parameters, particularly the adiponectin/leptin ratio.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Metabolic SyndromeGastric BypassObesity, MorbidDiabetes Mellitus, Type 2HumansFemaleLeptinAdiponectinObesityCholesterolGlucose

Stichwörter der Autor:innen

Roux-en-Y gastric bypassadiponectin to leptin ratioinflammatory profilemetabolic syndromeseverely obese

Substanzen

LeptinAdiponectinCholesterolGlucose

Autor:innen und Institutionen

  • Post Graduation Program in Health Sciences, Santa Casa of São Paulo Medical School, São Paulo 01224-001, SP, Brazil.
  • Post-Graduation Program in Health Sciences, Santo Amaro University (UNISA), São Paulo 04829-300, SP, Brazil.
  • Institute of Pharmaceutical Sciences, Goiania 74175-100, GO, Brazil.
  • Scientific Initiation Program, Evangelical University of Goiás (UniEVANGELICA), Anápolis 75083-515, GO, Brazil.
  • Department of Physical Therapy, School of Medicine, University of São Paulo, São Paulo 05360-000, SP, Brazil.
  • Human Movement and Rehabilitation Post Graduation Program, Evangelical University of Goiás (UniEVANGELICA), Anápolis 75083-515, GO, Brazil.

ORCID-Profile: André L L Bachi, Carlos A Malheiros, Juliana M B Santos, Rodolfo P Vieira, Giuseppe Insalaco, Luis V F Oliveira

Förderung

  • National Council for Scientific and Technological Development
  • Coordenação de Aperfeicoamento de Pessoal de Nível Superior
  • Fundação de Apoio a Pesquisa do Estado de Goiás
  • Coordenaçao de Apoio ao Pessoal de Nível Superior (CAPES/PROSUP)
  • Fundação de Amparo a Pesquisa (FAPEG)
  • Conselho Nacional de Desenvolvimento Científico e Tecnologico (local acronym CNPq)
  • Conselho Nacional de Desenvolvimento Cientifco e Tecnologico (local acronym CNPq)
  • Institute of Translational Pharmacology; National Research Council—CNR

Zitieren

APA

Moreira, S. M. B. P., Bachi, A. L. L., Jirjos, E. I., Malheiros, C. A., Vencio, S., Alves, V. L. S., Sousa, A. R. T., Felipe, L. A., Perez, E. A., Lino, M. E. M., Souza, S. K. A., Santos, J. M. B., Oliveira, M. C., Fonseca, A. L., Silva, C. H. M., Vieira, R. P., Insalaco, G., Freitas Júnior, W. R., & Oliveira, L. V. F. (2023). Roux-en-Y Gastric Bypass Improves Adiponectin to Leptin Ratio and Inflammatory Profile in Severely Obese Women with and without Metabolic Syndrome: A Randomized Controlled Trial. Nutrients. https://doi.org/10.3390/nu15153312

Vancouver

Moreira SMBP, Bachi ALL, Jirjos EI, Malheiros CA, Vencio S, Alves VLS, et al. Roux-en-Y Gastric Bypass Improves Adiponectin to Leptin Ratio and Inflammatory Profile in Severely Obese Women with and without Metabolic Syndrome: A Randomized Controlled Trial. Nutrients. 2023. doi:10.3390/nu15153312

BibTeX
@article{Moreira2023,
  author = {Moreira, Sandra M B P and Bachi, André L L and Jirjos, Elias I and Malheiros, Carlos A and Vencio, Sergio and Alves, Vera L S and Sousa, Alan R T and Felipe, Lucenda A and Perez, Eduardo A and Lino, Maria E M and Souza, Shayra K A and Santos, Juliana M B and Oliveira, Miriã C and Fonseca, Adriano L and Silva, Carlos H M and Vieira, Rodolfo P and Insalaco, Giuseppe and Freitas Júnior, Wilson R and Oliveira, Luis V F},
  title = {Roux-en-Y Gastric Bypass Improves Adiponectin to Leptin Ratio and Inflammatory Profile in Severely Obese Women with and without Metabolic Syndrome: A Randomized Controlled Trial},
  journal = {Nutrients},
  year = {2023},
  doi = {10.3390/nu15153312}
}
Kostenlos starten →